Matches in Wikidata for { <http://www.wikidata.org/entity/Q90790143> ?p ?o ?g. }
Showing items 1 to 63 of
63
with 100 items per page.
- Q90790143 description "2020 թվականին հրատարակված գիտական հոդված" @default.
- Q90790143 description "article scientifique (publié 2020)" @default.
- Q90790143 description "articolo scientifico (pubblicato il 2020)" @default.
- Q90790143 description "artigo científico (publicado na 2020)" @default.
- Q90790143 description "artikull shkencor i botuar më 01 janar 2020" @default.
- Q90790143 description "artículo científico publicado en 2020" @default.
- Q90790143 description "artículu científicu espublizáu en xineru de 2020" @default.
- Q90790143 description "im Jahr 2020 veröffentlichter wissenschaftlicher Artikel" @default.
- Q90790143 description "scientific article published on 01 January 2020" @default.
- Q90790143 description "wetenschappelijk artikel" @default.
- Q90790143 description "наукова стаття, опублікована 1 січня 2020" @default.
- Q90790143 description "научна статия" @default.
- Q90790143 name "Effectiveness and persistence of Vedolizumab in patients with inflammatory bowel disease : results from the Belgian REal-LIfe study with VEdolizumab (Be-RELIVE)" @default.
- Q90790143 name "Effectiveness and persistence of Vedolizumab in patients with inflammatory bowel disease : results from the Belgian REal-LIfe study with VEdolizumab (Be-RELIVE)" @default.
- Q90790143 name "Effectiveness and persistence of Vedolizumab in patients with inflammatory bowel disease : results from the Belgian REal-LIfe study with VEdolizumab (Be-RELIVE)" @default.
- Q90790143 type Item @default.
- Q90790143 label "Effectiveness and persistence of Vedolizumab in patients with inflammatory bowel disease : results from the Belgian REal-LIfe study with VEdolizumab (Be-RELIVE)" @default.
- Q90790143 label "Effectiveness and persistence of Vedolizumab in patients with inflammatory bowel disease : results from the Belgian REal-LIfe study with VEdolizumab (Be-RELIVE)" @default.
- Q90790143 label "Effectiveness and persistence of Vedolizumab in patients with inflammatory bowel disease : results from the Belgian REal-LIfe study with VEdolizumab (Be-RELIVE)" @default.
- Q90790143 prefLabel "Effectiveness and persistence of Vedolizumab in patients with inflammatory bowel disease : results from the Belgian REal-LIfe study with VEdolizumab (Be-RELIVE)" @default.
- Q90790143 prefLabel "Effectiveness and persistence of Vedolizumab in patients with inflammatory bowel disease : results from the Belgian REal-LIfe study with VEdolizumab (Be-RELIVE)" @default.
- Q90790143 prefLabel "Effectiveness and persistence of Vedolizumab in patients with inflammatory bowel disease : results from the Belgian REal-LIfe study with VEdolizumab (Be-RELIVE)" @default.
- Q90790143 P1433 Q90790143-2A022249-EE7F-417C-AAA1-9949B4C861DC @default.
- Q90790143 P1476 Q90790143-2189835B-2201-4502-98A1-23D5B25E5894 @default.
- Q90790143 P2093 Q90790143-0330A7B5-47AA-4819-8E4B-335AFE6BF584 @default.
- Q90790143 P2093 Q90790143-112D3D25-FA2E-4FF9-8AEA-A69192404F86 @default.
- Q90790143 P2093 Q90790143-19188B60-6EF4-4934-8706-CB7B26E3F4DD @default.
- Q90790143 P2093 Q90790143-3E3A4CB5-7D2B-433C-9247-D16F6CE363CE @default.
- Q90790143 P2093 Q90790143-5EFD5E9B-31A4-4F05-B558-AD56F4308E6D @default.
- Q90790143 P2093 Q90790143-71EEF25A-F265-41CA-A151-C887B57F560B @default.
- Q90790143 P2093 Q90790143-87991DE2-9159-46B9-828B-B3A9B4B5C42F @default.
- Q90790143 P2093 Q90790143-9196FE86-6A0C-4EB6-9BAE-2E2DC44A86D3 @default.
- Q90790143 P2093 Q90790143-AC2E9FD7-9119-48BE-A3FA-750B5259290A @default.
- Q90790143 P2093 Q90790143-C4AF75B9-BDDA-40DE-9C24-C2857084694D @default.
- Q90790143 P2093 Q90790143-EABB01FB-6D02-4A64-8C91-B5DBAC53301B @default.
- Q90790143 P304 Q90790143-E862B254-49D3-4FB1-9325-F81C4B5059F0 @default.
- Q90790143 P31 Q90790143-3C36771A-C0B4-401A-AC72-F953397B9DA9 @default.
- Q90790143 P433 Q90790143-2F4A5C03-2549-4043-92C8-E8B3F815895E @default.
- Q90790143 P478 Q90790143-E2A60C96-8080-4E63-9AAA-8D5CAAE68738 @default.
- Q90790143 P577 Q90790143-55382610-48B8-48E6-A715-B37BE975DAE4 @default.
- Q90790143 P698 Q90790143-7668166A-816C-43C6-8429-831C4F1F112B @default.
- Q90790143 P921 Q90790143-F5A77FD1-9651-45DF-91D9-011CE99E8587 @default.
- Q90790143 P698 32233267 @default.
- Q90790143 P1433 Q15758484 @default.
- Q90790143 P1476 "Effectiveness and persistence of Vedolizumab in patients with inflammatory bowel disease : results from the Belgian REal-LIfe study with VEdolizumab (Be-RELIVE)" @default.
- Q90790143 P2093 "A Cremer" @default.
- Q90790143 P2093 "A Hantson" @default.
- Q90790143 P2093 "B De Vroey" @default.
- Q90790143 P2093 "C Reenaers" @default.
- Q90790143 P2093 "J Imschoot" @default.
- Q90790143 P2093 "O Dewit" @default.
- Q90790143 P2093 "P Bossuyt" @default.
- Q90790143 P2093 "P Van Hootegem" @default.
- Q90790143 P2093 "S Block" @default.
- Q90790143 P2093 "V Muls" @default.
- Q90790143 P2093 "W Van Moerkercke" @default.
- Q90790143 P304 "15-23" @default.
- Q90790143 P31 Q13442814 @default.
- Q90790143 P433 "1" @default.
- Q90790143 P478 "83" @default.
- Q90790143 P577 "2020-01-01T00:00:00Z" @default.
- Q90790143 P698 "32233267" @default.
- Q90790143 P921 Q917447 @default.